Nicole LaBrosse - 16 Feb 2024 Form 4 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Role
SVP, CHIEF FINANCIAL OFFICER
Signature
/s/ James R. Oehler, Attorney-in-Fact
Issuer symbol
HALO
Transactions as of
16 Feb 2024
Net transactions value
-$202,196
Form type
4
Filing time
20 Feb 2024, 18:53:11 UTC
Previous filing
16 Feb 2024
Next filing
27 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HALO Common Stock Options Exercise $0 +5,093 +48% $0.000000 15,752 16 Feb 2024 Direct
transaction HALO Common Stock Tax liability $98,806 -2,737 -17% $36.10 13,015 16 Feb 2024 Direct F1
transaction HALO Common Stock Options Exercise $0 +5,329 +41% $0.000000 18,344 16 Feb 2024 Direct
transaction HALO Common Stock Tax liability $103,390 -2,864 -16% $36.10 15,480 16 Feb 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HALO Restricted Stock Units Options Exercise $0 -5,093 -33% $0.000000 10,186 16 Feb 2024 Common Stock 5,093 $0.000000 Direct F3
transaction HALO Restricted Stock Units Options Exercise $0 -5,329 -25% $0.000000 15,987 16 Feb 2024 Common Stock 5,329 $0.000000 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported disposition of 2,737 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
F2 The reported disposition of 2,864 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
F3 This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.